These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 11097606

  • 1. Vitrectomy in eyes with unsuspected retinoblastoma.
    Shields CL, Honavar S, Shields JA, Demirci H, Meadows AT.
    Ophthalmology; 2000 Dec; 107(12):2250-5. PubMed ID: 11097606
    [Abstract] [Full Text] [Related]

  • 2. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [Abstract] [Full Text] [Related]

  • 3. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC, Qaddoumi I, Billups CA, Free TL, Haik BG, Rodriguez-Galindo C, Wilson MW.
    Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
    Kletke SN, Feng ZX, Hazrati LN, Gallie BL, Soliman SE.
    Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
    Fabian ID, Stacey AW, Chowdhury T, Duncan C, Karaa EK, Scheimberg I, Reddy MA, Sagoo MS.
    Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
    Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW.
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma].
    Deng X, Cheng Y, Zhu XM, Linghu DD, Zhao MW, Liang JH.
    Zhonghua Yan Ke Za Zhi; 2020 Sep 11; 56(9):681-687. PubMed ID: 32907301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.